Behavioral and Neural Biology 2015-01-01

Retention enhancement by pre-test beta-endorphin and oxotremorine and its reversal by scopolamine.

Tom Sieprath, Tobias D J Corne, Marco Nooteboom, Charlotte Grootaert, Andreja Rajkovic, Benjamin Buysschaert, Joke Robijns, Jos L V Broers, Frans C S Ramaekers, Werner J H Koopman, Peter H G M Willems, Winnok H De Vos

Index: Behav. Neural Biol 50(3) , 251-4, (1988)

Full Text: HTML

Abstract

The pre-test administration of beta-endorphin (0.05 microgram/mouse), oxotremorine sesquifumarate (5.0 micrograms/mouse), or beta-endorphin plus oxotremorine enhanced retention test performance of a conditioned emotional response in mice. The effects were blocked by scopolamine. Scopolamine had no effect of its own. The data suggest that the retention enhancement caused by beta-endorphin may involve the secondary activation of cholinergic mechanisms.


Related Compounds

Related Articles:

Acetylcholine activity in selective striatal regions supports behavioral flexibility.

2009-01-01

[Neurobiol. Learn. Mem. 91(1) , 13-22, (2009)]

Stress-induced immobility in rats with cholinergic supersensitivity.

1986-06-01

[Biol. Psychiatry 21(7) , 657-64, (1986)]

Memory-modulatory effects of centrally acting noradrenergic drugs: possible involvement of brain cholinergic mechanisms.

1992-05-01

[Behav. Neural Biol 57(3) , 248-55, (1992)]

Acetylcholine via muscarinic receptors inhibits histamine release from human isolated bronchi.

1997-08-01

[Am. J. Respir. Crit. Care Med. 156(2 Pt 1) , 389-95, (1997)]

An in vivo pharmacological study on muscarinic receptor subtypes regulating cholinergic neurotransmission in rat striatum.

1987-09-15

[Biochem. Pharmacol. 36(18) , 3075-7, (1987)]

More Articles...